Showing results (1831-1840 of 3,100) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|July 25, 2015
Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancerJohn Syrios, Georgios Nintos, Vassilis GeorgouliasExpert Review of Anticancer Therapy|June 25, 2015
Trametinib in metastatic melanomaNeha Chopra, Paul D NathanExpert Review of Anticancer Therapy|June 2, 2015
Current treatment options for dermatofibrosarcoma protuberansPiotr Rutkowski, Maria Debiec-RychterExpert Review of Anticancer Therapy|June 3, 2015
Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinomaRalf-Dieter Hofheinz, Sylvie LorenzenExpert Review of Anticancer Therapy|June 3, 2015
Tivantinib (ARQ197) in hepatocellular carcinomaCamillo Porta, Palma Giglione, Alessandra Ferrari, et al.Expert Review of Anticancer Therapy|July 14, 2015
Echo-endoscopic lymph node staging in lung cancer: an endoscopic alternativePravachan Hegde, Moishe LibermanExpert Review of Anticancer Therapy|June 2, 2020
Myelodysplastic syndromes: a review of therapeutic progress over the past 10 yearsJonathan Feld, Abigail Belasen, Shyamala C NavadaExpert Review of Anticancer Therapy|March 22, 2003
Chemoradiotherapy of non-small cell lung cancerJacek JassemExpert Review of Anticancer Therapy|March 22, 2003
Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization projectMellar P Davis, Elias Khawam, Leo Pozuelo, et al.Expert Review of Anticancer Therapy|June 25, 2003
Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinaseAnca M Bulgaru, Sridhar Mani, Sanjay Goel, et al.Pageof 310